Advertising

Therapeutic Radiology and Oncology (TRO), launched in September 2017, and originated in 1994 and known in the field as the Blue Journal, publishes papers describing original research, case reports and clinical investigations related to radiation oncology. This includes clinical radiotherapy, radiobiology, chemotherapy, immunotherapy, hyperthermia, tumor biology, experimental therapeutics and clinical oncology. It also covers fields of medical physics, radiology, nursing care, education, technology, health information and health policy as it relates to radiology and oncology.

Advancements in therapeutic radiology and oncology have allowed physicians to better treat their patients with cooperation from multidisciplinary team members. The Journal TRO focuses on the most recent advances on a worldwide basis. It plays as a professional and comprehensive platform for readership relating to radiology and oncology.

The journal welcomes a wide range of submission types, including high-quality research, clinical trials reports, technique reports, review articles, editorial letter, etc. Articles will be solicited from recognized experts in these fields, while submissions for peer review will also be considered. The high quality of its content is assured by a rigorous review process, supervised by an international editorial board.

As such, the journal provides an excellent base for strategic placement of advertisements reaching key audiences in the field of radiology and oncology.

What we can offer?
  • Advances online advertising.
  • Personalized, customer support at any level by a publishing group experience with print and on-line platforms.
  • Bilingual advertisement (English and Chinese) per request.

  • Please feel free to contact us for more details:
  • AME Publishing Company
  • Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT
  • Phone: +86 20 66355775
  • Email: tro@amegroups.com